HomeMedia
Media
Origins Council Requests Governor’s Signature on California’s AB 1111 Direct-to-Consumer Cannabis Sales Bill
Origins Council is dedicated to the sustainable development of California’s heritage cannabis producing regions.
Small farmers urge Gov. Newsom to sign Assemblymember Gail Pellerin’s bill allowing consumer direct sales at cannabis events
AB 1111 is just the type of policy we need...
CamScanner Launches Campus Program, Empowering University Students and Faculty across the World
Company will sponsor academic events, seminars, and various on-campus activities through CamScanner premium accounts and other support
New York, Aug. 30, 2024 (GLOBE NEWSWIRE) -- CamScanner, a global leader in document-scanning apps with...
Imbria to Present Results from Phase 2 IMPROVE-ISCHEMIA Trial of Ninerafaxstat in Patients with Angina and Chronic Coronary Syndrome at the European Society of...
– Ninerafaxstat was well tolerated and showed no impact on systemic hemodynamics in patients with stable angina and chronic coronary syndrome – – These findings support a direct, metabolically-mediated, anti-ischemic effect of ninerafaxstat...
Collegium to Participate in H.C. Wainwright 26th Annual Global Investment Conference
STOUGHTON, Mass., Aug. 30, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading, diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions, today announced...
CG Oncology to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
IRVINE, Calif., Aug. 30, 2024 (GLOBE NEWSWIRE) -- CG Oncology, Inc. (NASDAQ: CGON), a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients with bladder...
Disc Medicine to Participate in Upcoming Investor Conferences
WATERTOWN, Mass., Aug. 30, 2024 (GLOBE NEWSWIRE) -- Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic...